Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It

As a main subtype of lung cancer, the current situation of non-small cell lung cancer (NSCLC) remains severe worldwide with a 19% survival rate at 5 years. As the conventional therapy approaches, such as chemotherapy, radiotherapy, targeted therapy, and immunotherapy, gradually develop into therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Jiayu, Wang, Li, Tang, Hailin, Liu, Xiuxiu, Peng, Fu, Peng, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704137/
https://www.ncbi.nlm.nih.gov/pubmed/34948133
http://dx.doi.org/10.3390/ijms222413335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704137/
https://www.ncbi.nlm.nih.gov/pubmed/34948133
http://dx.doi.org/10.3390/ijms222413335

Ejemplares similares